AUS
NZ
UK
CA
USA
IND
Healthcare
Sigma Healthcare announced full-year results
March 22, 2019 03:23 PM AEDT| By Team Kalkine MediaAustralia?s Pharmacy wholesaler, Sigma Healthcare Limited (ASX: SIG) has announced its full-year results for the year ended 31st January 2019. The company marked a decline in sales revenue and reported the underlying sales revenue of $3976.8 million...
Cann Group released its investors' presentation: Stock zoomed up by 9.95%
March 21, 2019 10:56 PM AEDT| By Team Kalkine MediaCann Group Limited (ASX: CAN) is in the business of legal cannabis production and sales for medical purpose and is making an effort to tap the medical cannabis market. The first medicinal cannabis cultivation licence and medicinal cannabis research l...
Compumedics’ Shares arrowed up on signing a supply agreement with US-based Adventist
March 21, 2019 10:50 PM AEDT| By Team Kalkine MediaCompumedics Limited (ASX: CMP) ?is a medical device company which manufactures, develops and commercialises technology in regard to the diagnosis monitoring applications for the sleep, brain and ultrasonic blood-flow. The company has global footprint...
Is this healthcare stock under investors' radar - ASX: NOX?
March 21, 2019 07:18 PM AEDT| By Team Kalkine MediaA drug development company, Noxopharm Limited (ASX: NOX) announced that Goodridge Nominees Pty Ltd has become a new substantial holder in the company on 19 March 2019. This comes after the Goodridge Nominees acquired 5.43 million more shares in Noxop...
Cynata Therapeutics completes the clinical study report on the Phase-1 of CYP-001
March 21, 2019 05:32 PM AEDT| By Team Kalkine MediaClinical-stage Biotechnology company, Cynata Therapeutics Limited (ASX: CYP) unveils its clinical study report on the first-ever clinical trial utilizing induced pluripotent stem cell (iPSC)-derived therapy. In the announcement dated 21 March 2019,...
Impression HealthCare Collaborates with Cannvalate Pty for Clinical Trials and Sale of Cannabis Medicines
March 21, 2019 05:15 PM AEDT| By Team Kalkine MediaImpression HealthCare Limited (ASX: IHL) provides new ways for consumers to access high-quality, personalized, dental health products. It aims at disrupting the way Australians access quality, custom-fit mouth-guards and also making them approachable...
Wattle Health Announces Supply Agreement with ISDC for the Chinese Market
March 20, 2019 10:20 PM AEDT| By Team Kalkine MediaWattle Health Australia Limited (ASX: WHA) announces the finalisation of its legally binding supply agreement with the International Supplies and Distribution Company (ISDC) to supply its standard infant formula product range to the Chinese market....
Genetic Technologies Releases Investor Presentation Report
March 20, 2019 10:03 PM AEDT| By Team Kalkine MediaMolecular Diagnostic Company Genetic Technologies Limited (ASX: GTG) is an ASX and NASDAQ (GENE) listed company with specialization in women?s health through its predictive testing and assessment tools. Its product BREVAGenplus? helps in assessing no...
Imugene provides Guidance for KEY-Vaxx Cancer Immunotherapy
March 20, 2019 07:31 PM AEDT| By Team Kalkine MediaImugene Limited (ASX: IMU) is an ASX listed biotechnology company based in Sydney, Australia. The company?s primary focus is on the cancer immunotherapy by developing a range of new and novel immunotherapies that can activate the immune system of can...
Healthscope Limited Gets FIRB Approval For Brookfield Transaction
March 20, 2019 06:36 PM AEDT| By Team Kalkine MediaHealthscope Limited (ASX: HSO) provides healthcare services. The Company manages a network of hospitals, clinics, and physicians for the provision of emergency care, women's facilities, cancer care, and pediatric services. Healthscope serves customer...
Blackmores Announces The Change In Leadership Structure Following The Resignation Of CEO
March 20, 2019 04:41 PM AEDT| By Team Kalkine MediaBlackmores Limited (ASX: BKL) today confirmed the resignation of Richard Henfrey who will step down as a Chief Executive Officer and Managing Director of the company with effect from 29 March 2019. The news sent the stock price to dip by 1.312% to st...
SUDA Pharmaceuticals develops oral spray product for cancer prevention
March 20, 2019 03:27 PM AEDT| By Team Kalkine MediaA drug-delivery pharmaceutical company, SUDA Pharmaceuticals has recently identified the use of platelets as surrogate biomarkers in cancer risk that can potentially reduce the economic burden from cancer incidence at risk individuals. SUDA Pharmace...
5 Most Talked About Stocks In Healthcare Space - CYP, MSB, MMJ, HSO And NAN
March 19, 2019 07:30 PM AEDT| By Team Kalkine MediaCynata Therapeutics Limited The Carlton-based Cynata Therapeutics Limited (ASX: CYP) is a clinical-stage biotechnology company engaged in developing and commercialising its flagship product Cymerus, based on its proprietary mesenchymal stem cell te...
Immuron updates about drug candidate IMM-529; obtains new US patent from USPTO
March 19, 2019 06:29 PM AEDT| By Team Kalkine MediaImmuron Limited (ASX: IMC) is an Australian based biopharmaceutical company. It is engaged with marketing and selling of Travelan in Australia for the prevention of Travellers? Diarrhea. IMC also markets it in the USA and Canada as a dietary suppleme...
Kazia Therapeutics Sells Its Remaining Stake in Noxopharm; Gross Proceeds From Sale Amounts To $2.4 Million
March 19, 2019 03:38 PM AEDT| By Team Kalkine MediaThe Sydney based oncology-focused biotech company, Kazia Therapeutics Limited (ASX: KZA) today announced that it has entered into an arrangement to sell the remainder of its holding in the shares of Noxopharm limited (ASX: NOX) via a block trade. Th...
Cann Group’s shares surged 19% on a Revised Expansion Plan and Offtake Agreement
March 19, 2019 02:41 PM AEDT| By Team Kalkine MediaCann Group Limited (ASX: CAN) is one of the few companies which is trying to tap the medical cannabis market by providing access to medicinal cannabis for patients. It was issued the first medicinal cannabis research licence and first medicinal canna...
ResApp Health announced significant outcomes obtained from SMARTCOUGH-C-2 Study
March 18, 2019 08:00 PM AEDT| By Team Kalkine MediaThe leading digital healthcare company, ResApp Health Limited (ASX: RAP) declared the top-line outcomes for croup and primary upper respiratory tract disease (URTD) attained from the study of SMARTCOUGH-C-2. SMARTCOUGH-C-2 is a double-blind, prospec...
Rhythm Biosciences Recruits First Patient At ColoSTAT’s Lyell McEwin Study Site
March 18, 2019 06:27 PM AEDT| By Team Kalkine MediaThe Melbourne-based Rhythm Biosciences Limited (ASX: RHY), established in 2017, is a company that develops and commercialises a screening and diagnostic tool for the early stage detection of colorectal cancer in the global mass market. Its flagship p...
Jayex Healthcare Is All Set To Capture New Zealand Cannabis Market With Its Revised Strategy
March 18, 2019 05:56 PM AEDT| By Team Kalkine MediaJayex Healthcare Limited (ASX: JHL) is in the business of healthcare sector. The company has specifically focused on healthcare technology from the last 25 years by creating several products and acquiring Australia?s number one appointment booking ap...
Alcidion Group Announces ~$2.1 Mn Deal With Dartford And Gravesham NHS Trust
March 18, 2019 05:16 PM AEDT| By Team Kalkine MediaAlcidion Group Limited (ASX: ALC) announced a strategic partnership worth ~$2.1 Mn with Dartford and Gravesham NHS trust in the UK, over a period of 5 years. The trust will be Alcidion?s first customer outside Australia to adopt its complete product...
Advertise your brand on Kalkine Media